Editorial: mesalazine to prevent recurrent acute diverticulitis—the final nail in the coffin. Authors’ reply

por Kruis, W., Greinwald, R.
Publicado 2017

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

por Kruis, W, Kiudelis, G, Rácz, I, Gorelov, I A, Pokrotnieks, J, Horynski, M, Batovsky, M, Kykal, J, Boehm, S, Greinwald, R, Mueller, R
Publicado 2009

Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence

por Kruis, W., Kardalinos, V., Eisenbach, T., Lukas, M., Vich, T., Bunganic, I., Pokrotnieks, J., Derova, J., Kondrackiene, J., Safadi, R., Tuculanu, D., Tulassay, Z., Banai, J., Curtin, A., Dorofeyev, A. E., Zakko, S. F., Ferreira, N., Björck, S., Diez Alonso, M. M., Mäkelä, J., Talley, N. J., Dilger, K., Greinwald, R., Mohrbacher, R., Spiller, R.
Publicado 2017